Flashpoint Therapeutics is a company developing nanotechnology-enabled therapeutics for cancer and other diseases, using their proprietary nanotechnology platform to deliver precise combinations of therapeutic components.

Azul 3D is a 3D printing startup that has developed High-Area Rapid Printing (HARP™) technology, and with the recent Series A funding round, they plan to scale production and disrupt the 3D printing space by digitizing traditional manufacturing methods.